The US Food and Drug Administration will move into the process of drafting an implementable Quality Management Maturity rating system after a 2 November public endorsement of the concept from its Pharmaceutical Science & Clinical Pharmacology Advisory Committee.
The committee review amounted to the final stop on FDA’s process to build support at the conceptual level for the...